Potorac, I, Petrossians, P, Daly, AF, Alexopoulou, O, Borot, S, Sahnoun-Fathallah, M, Castinetti, F, Devuyst, F, Jaffrain-Rea, ML, Briet, C, de Luca, F, Lapoirie, M, Zoicas, F, Simoneau, I, Diallo, AM, Muhammad, A, Kelestimur, F, Nazzari, E, Centeno, RG, Webb, SM, Nunes, ML, Hana, V, Pascal-Vigneron, V, Ilovayskaya, I, Nasybullina, F, Achir, S, Ferone, D
, Neggers, SJCMM, Delemer, B, Petit, JM, Schofl, C, Raverot, G, Goichot, B, Rodien, P, Corvilain, B, Brue, T, Schillo, F, Tshibanda, L, Maiter, D, Bonneville, JF & Beckers, A 2016, '
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly',
Endocrine-Related Cancer, vol. 23, no. 11, pp. 871-881.
https://doi.org/10.1530/ERC-16-0356